Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational Study to Assess the Performance of CAA Measurement as a Diagnostic Tool for the Detection of Schistosoma Haematobium Infections in Pregnant Women and Their Newborn and Child in Lambaréné, Gabon

NCT03779347 is registered in ClinicalTrials.gov with Centre de Recherche Médicale de Lambaréné as lead sponsor.

NCT NCT03779347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03779347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational Study to Assess the Performance of CAA Measurement as a Diagnostic Tool for the Detection of Schistosoma Haematobium Infections in Pregnant Women and Their Newborn and Child in Lambaréné, Gabon
Lead sponsor
Centre de Recherche Médicale de Lambaréné
Phase
Phase 3
Overall status
Unknown status
Start date
May 1, 2019
Completion date
May 1, 2022
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diagnostic, drug reaction, pregnancy, schistosomiasis hematobium